Efficacy of Live Attenuated Dengue Vaccines: CYD-TDV; TDV (TAK-003) and TV003/TV005

نویسندگان

چکیده

Highlight:Differences in the efficacy of CYD-TDV versus other TAK-003 and TV003/TV005 were discussed.One licensed dengue vaccine is (Dengvaxia). Abstract:Dengue fever most common tropical disease, but there still remains no specific therapy that can overcome it. Special attention needs to be paid this because large increases incidence last decade. As an effective preventive strategy, finding a new for with higher potentiation highly necessary stop transmission especially endemic area. Vaccine triggers immune response, so it create robust response when infected. Nowadays, only one However, has many weaknesses, namely its dependency on serostatus recipient. There are also vaccines ongoing clinical testing have promising results, TDV (TAK-003) TV003/TV005. These three live attenuated various results. This review discussed differences against TV003/TV005; considering known unknown factors.

برای دانلود رایگان متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Safety and Immunogenicity of Recombinant, Live Attenuated Tetravalent Dengue Vaccine (CYD- TDV) in Healthy Vietnamese Adults and Children

Background: Dengue viruses (DENV1-4) are estimated to infect 50-100 million individuals per year worldwide including an estimated 500,000 people with severe dengue who require hospitalization every year. The live, attenuated, tetravalent dengue vaccine (CYD-TDV) candidate, containing four recombinant dengue viruses (CYD14), is in clinical phase III. Methods: In an observer-blind, phase II trial...

متن کامل

CYD-TDV dengue vaccine: systematic review and meta-analysis of efficacy, immunogenicity and safety.

INTRODUCTION Dengue virus (DENV) is a serious global health problem. CYD-TDC (Dengvaxia®) was the first vaccine to gain regulatory approval to try and address this problem. AIM Summarize all available evidence on the immunogenicity, efficacy and safety of the CYD-TDV dengue vaccine. METHOD Meta-analysis and systematic review. RESULTS The best and worst immunogenicity results were for DENV...

متن کامل

Clinical Efficacy, Safety, and Immunogenicity of a Live Attenuated Tetravalent Dengue Vaccine (CYD-TDV) in Children: A Systematic Review with Meta-analysis

BACKGROUND Dengue hemorrhagic fever is the leading cause of hospitalization and death in children living in Asia and Latin America. There is an urgent need for an effective and safe dengue vaccine to reduce morbidity and mortality in this high-risk population given the lack of dengue specific treatment at present. This review aims to determine the efficacy, safety, and immunogenicity of CYD-TDV...

متن کامل

The Immunogenicity and Safety of CYD-Tetravalent Dengue Vaccine (CYD-TDV) in Children and Adolescents: A Systematic Review.

AIM to assess the immunogenicity and safety of CYD-tetravalent dengue vaccine (CYD-TDV) in children. METHODS comprehensive literature searches were conducted on various databases. Randomized-controlled trials on children with CYD-TDV as intervention were selected based on inclusion and exclusion criteria. Data extracted from selected trials included safety of vaccine and immunogenicity in ter...

متن کامل

Immunogenicity and safety of recombinant tetravalent dengue vaccine (CYD-TDV) in individuals aged 2–45 years

This was a multicenter, blinded, Phase II study (NCT00880893) conducted in Singapore. The primary objectives were to evaluate the safety of a tetravalent dengue vaccine (TDV) comprising four recombinant, live, attenuated viruses (CYD-TDV) and the dengue virus serotype-specific antibody responses before and 28 d after each vaccination. Participants were randomized 3:1 to receive three doses of C...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

ژورنال

عنوان ژورنال: Folia Medica Indonesiana

سال: 2021

ISSN: ['2355-8393', '2599-056X']

DOI: https://doi.org/10.20473/fmi.v57i4.21741